12 Lots of Smoking Cessation Drug Recalled Due to Contamination
On July 16, 2021, Pfizer announced that it was recalling 12 lots of its smoking cessation drug Chantix due to the presence of a chemical that’s linked to an increased risk of cancer in humans. According to a press release by the U.S. Food and Drug Administration, the recalled lots include two lots of 0.5mg tablets, two lots of 1mg tablets, and eight lots of a mixture of 0.5mg tablets and 1mg tablets.
The affected tablets contain a chemical called N-nitroso-varenicline, which can increase the risk of cancer in people who are exposed to it over a long period. Nitrosamines are present in many foods, and exposure is almost impossible to prevent. However, when people are exposed to higher levels than normal over a long period, they can develop certain types of cancer.
As with all recalled medications, you shouldn’t stop taking Chantix without speaking to your doctor first. It’s also important to note that the FDA indicates there’s no immediate risk to patients taking the recalled lots of Chantix. But taking it and other medications that can increase the risk of cancer is something to discuss with your doctor, as you may be able to swap those medications for others that don’t increase your cancer risk.
At Ferrer, Poirot & Wansbrough, we’re always on the lookout for new recalls of drugs that can put consumers and patients at risk. If you or someone you love was hurt by a recalled medication, we want to speak with you. Fill out a free consultation form to get in touch with our drug injury lawyers today.